# New Zealand Pharmaceutical Ltd. – FDA Inspection, May 25, 2018

Source: https://www.keypedia.com/records/fda_inspections/new-zealand-pharmaceutical-ltd/8350e299-7ca6-445d-b4ce-48a6cde8c043
Source feed: FDA_Inspections

> FDA inspection 1055011 of New Zealand Pharmaceutical Ltd., May 25, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1055011
- Company Name: New Zealand Pharmaceutical Ltd.
- Inspection Date: 2018-05-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1274273 - 2025-05-16](https://www.keypedia.com/records/fda_inspections/new-zealand-pharmaceutical-ltd/43202d21-87ac-4ca7-ba10-53ffce8083da)
- FDA Inspection 883556 - 2014-05-16

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)

Company: https://www.keypedia.com/companies/new-zealand-pharmaceutical-ltd/9cd5ef7a-17ab-4c6b-a010-3b79934ee9ea

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c